Pharmaxis Announces First Sales of Aridol® in USA

13th Dec 18

Release Date: 13/12/2018 8:30am

Pharmaceutical research company Pharmaxis (ASX: PXS) today announced the first sales of its asthma diagnostic Aridol® (mannitol bronchial challenge test) in the United States following the relaunch of the product.

Read full media release - pdf

Categories: News and Media